Novartis Hit With $250K Verdict In Zometa Jaw Injury Suit

Law360, New York (March 4, 2013, 8:00 PM EST) -- A Florida jury slapped Novartis Pharmaceuticals Corp. with a $250,000 verdict on Wednesday in multidistrict litigation over injuries allegedly caused by the bone drug Zometa, though it declined to impose punitive damages on the drugmaker.

The plaintiff, Florida resident J. Hunter Chiles, claimed that Novartis failed to warn that Zometa, a bisphosphonate he took to treat his multiple myeloma, could cause the bone disease osteonecrosis of the jaw. The suit is part of the multidistrict litigation targeting Zometa and an older Novartis bone drug, Aredia....
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Chiles v. Novartis Pharmaceuticals Corporation


Case Number

3:06-cv-00096

Court

Florida Middle

Nature of Suit

Personal Inj. Prod. Liability

Judge

Henry Lee Adams, Jr

Date Filed

January 31, 2006

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.